Ashok Yadav/LinkedIn
Feb 26, 2026, 15:39
Ashok Yadav: Placental Glycogen as a Vital Energy Reserve for Fetal and Placental Health
Ashok Yadav, Biology Educator of Biology Faculty at Apex Academy, shared a post on LinkedIn:
”Placental glycogen storage serves as a vital energy reserve, primarily thought to support fetal growth and maintain glucose levels when maternal supply fluctuates. While its exact function in humans is still debated, animal models provide significant evidence for its role in both fetal development and placental health.
Functions of Placental Glycogen
- Fetal Energy Support: It is widely hypothesized that placental glycogen acts as a ‘buffer,’releasing glucose during periods of high fetal demand, particularly in late gestation.
- Local Placental Fuel: The placenta is a highly metabolic organ; glycogen stores may provide direct energy for its own functions, such as hormone production and maintaining vasomotor activity in placental blood vessels.
- Pathological Protection: In cases of maternal diabetes, the placenta may store excess glucose as glycogen to protect the fetus from hyperglycemia.
Dynamics and Storage Locations
- Temporal Peaks: In humans, glycogen accumulation peaks in the first trimester and declines toward term. In mice, it peaks around embryonic day 15.5.
- Cellular Storage:
- Mice: Specialized glycogen trophoblast cells in the junctional zone are the primary storage site.
- Humans: Storage occurs in extravillous trophoblasts (EVTs) located in the basal plate.
Clinical Significance
- Growth Complications: Both abnormally high and low placental glycogen levels are linked to Intrauterine Growth Restriction (IUGR) and pre-eclampsia.
- Diabetes: Maternal diabetes often leads to aberrant glycogen storage, which can disrupt normal metabolic communication between mother and fetus.
- Genetic Disorders: Rare conditions like Glycogen Storage Disease Type IV can show specific placental involvement, potentially allowing for prenatal diagnosis via biopsy.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia